Thomas E Exner
Overview
Explore the profile of Thomas E Exner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Punz B, Brajnik M, Dokler J, Amos J, Johnson L, Reilly K, et al.
Beilstein J Nanotechnol
. 2025 Jan;
16:57-77.
PMID: 39877837
Nanosafety assessment, which seeks to evaluate the risks from exposure to nanoscale materials, spans materials synthesis and characterisation, exposure science, toxicology, and computational approaches, resulting in complex experimental workflows and...
2.
Kolokathis P, Sidiropoulos N, Zouraris D, Varsou D, Mintis D, Tsoumanis A, et al.
Comput Struct Biotechnol J
. 2024 Nov;
25:256-268.
PMID: 39555474
Modelling Data (MODA) reporting guidelines have been proposed for common terminology and for recording metadata for physics-based materials modelling and simulations in a CEN Workshop Agreement (CWA 17284:2018). Their purpose...
3.
Mortensen H, Amos J, Exner T, Flores K, Harper S, Jarabek A, et al.
Comput Toxicol
. 2024 Oct;
30.
PMID: 39381054
The National Nanotechnology Initiative organized a Nanoinformatics Conference in the 2023 Biden-Harris Administration's Year of Open Science, which included interested U.S. and EU stakeholders, and preceded the U.S.-EU COR meeting...
4.
Pons J, Reys V, Grand F, Moreau V, Gracy J, Exner T, et al.
J Mol Biol
. 2024 Sep;
436(17):168704.
PMID: 39237192
Knowledge of protein-ligand complexes is essential for efficient drug design. Virtual docking can bring important information on putative complexes but it is still far from being simultaneously fast and accurate....
5.
Jennings P, Carta G, Singh P, da Costa Pereira D, Feher A, Dinnyes A, et al.
Cell Biol Toxicol
. 2022 Dec;
39(4):1773-1793.
PMID: 36586010
Transcriptomic analysis is a powerful method in the utilization of New Approach Methods (NAMs) for identifying mechanisms of toxicity and application to hazard characterization. With this regard, mapping toxicological events...
6.
van Rijn J, Afantitis A, Culha M, Dusinska M, Exner T, Jeliazkova N, et al.
J Cheminform
. 2022 Aug;
14(1):57.
PMID: 36002868
Management of nanomaterials and nanosafety data needs to operate under the FAIR (findability, accessibility, interoperability, and reusability) principles and this requires a unique, global identifier for each nanomaterial. Existing identifiers...
7.
Paini A, Campia I, Cronin M, Asturiol D, Ceriani L, Exner T, et al.
Comput Toxicol
. 2022 Feb;
21:100195.
PMID: 35211660
The adverse outcome pathway (AOP) is a conceptual construct that facilitates organisation and interpretation of mechanistic data representing multiple biological levels and deriving from a range of methodological approaches including...
8.
Singh P, Chandrasekaran V, Hardy B, Wilmes A, Jennings P, Exner T
Toxicol In Vitro
. 2021 Aug;
76:105229.
PMID: 34352368
Cadmium is a well-studied environmental pollutant where the kidney and particularly the proximal tubule cells are especially sensitive as they are exposed to higher concentrations of cadmium than other tissues....
9.
Papadiamantis A, Klaessig F, Exner T, Hofer S, Hofstaetter N, Himly M, et al.
Nanomaterials (Basel)
. 2020 Oct;
10(10).
PMID: 33076428
The emergence of nanoinformatics as a key component of nanotechnology and nanosafety assessment for the prediction of engineered nanomaterials (NMs) properties, interactions, and hazards, and for grouping and read-across to...
10.
Krebs A, van Vugt-Lussenburg B, Waldmann T, Albrecht W, Boei J, Ter Braak B, et al.
Arch Toxicol
. 2020 Jul;
94(7):2435-2461.
PMID: 32632539
Hazard assessment, based on new approach methods (NAM), requires the use of batteries of assays, where individual tests may be contributed by different laboratories. A unified strategy for such collaborative...